Procter & Gamble Health Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs)
Procter & Gamble Health Ltd · Outcome · 02 Nov 2026, 8:13 pm
Procter & Gamble Health Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs) ■ Revenue: 38,249 (+17.7% YoY | +5.2% QoQ) ■ EBITDA: 15,237 (+26.7% YoY | +53.0% QoQ) ■ EBITDA Margin (%): 39.8 (+282 bps YoY | +1245 bps QoQ) ■ PAT: 11,151 (+25.9% YoY | +16.0% QoQ) ■ EPS (INR): 67.2 (+25.9% YoY | +73.3% QoQ)
Original exchange filing (PDF)
More announcements from Procter & Gamble Health Ltd
- Stock Exchange is informed about an update on Ease of Investment - Special Window for Transfer and Dematerialization. · 17 Nov 2026
- Intimation for Change in Corporate Office address of Registrar and Share Transfer Agent (RTA) · 13 Nov 2026
- Press release for the unaudited financial results for the quarter ended September 30, 2026. · 02 Nov 2026
- Outcome of Board Meeting for the Quarter Ended September 30, 2026 · 02 Nov 2026
- Procter & Gamble Health Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 02 Nov 2026
- PROCTER & GAMBLE HEALTH LIMITED has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . · 02 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 02 Nov 2026
- Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve unaudited financial .... · 02 Nov 2026
